Knight Therapeutics Inc. - PE Ratio
KHTRF
Price:
$6.7
Market Cap:
$910.12M
Knight Therapeutics Inc. operates as a specialized pharmaceutical enterprise, actively engaged in the development, acquisition, in-licensing, out-licensing, marketing, and distribution of a broad spectrum of pharmaceutical goods, consumer health solutions, and medical devices. Its operational footprint extends across Canada, Latin America, and other global markets. The company's extensive product offerings encompass treatments like Nerlynx, targeting extended adjuvant and metastatic breast cancer; Tafasitamab, prescribed for relapsed or refractory diffuse large B-cell lymphoma; and Pemigatinib, designed for metastatic cholangiocarcinoma. It also provides Trelstar for advanced prostate cancer...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2014-04-03
Stock Exchange
OTC
Ticker
KHTRF
PE Ratio
[167.50]
ROE
[0.73%]
Current Ratio
[2.32]
Dividend Yield
[0%]
Enterprise Value
[871.85M]
Dividend History
The PE Ratio as of June 2026 (TTM) for Knight Therapeutics Inc. (KHTRF) is 167.50
According to Knight Therapeutics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 167.50. This represents a change of -3681.27% compared to the average of -4.68 of the last 4 quarters.
Knight Therapeutics Inc. (KHTRF) Historical PE Ratio (quarterly & annually)
How has KHTRF PE Ratio performed in the past?
The mean historical PE Ratio of Knight Therapeutics Inc. over the last ten years is 28.41. The current 167.50 PE Ratio has changed 58.87% with respect to the historical average. Over the past ten years (40 quarters), KHTRF's PE Ratio was at its highest in in the September 2024 quarter at 1.85K. The PE Ratio was at its lowest in in the March 2020 quarter at -123.02.
Average
28.41
Median
43.00
Minimum
-112.04
Maximum
124.77
Knight Therapeutics Inc. (KHTRF) PE Ratio by Quarter and Year
Discovering the peaks and valleys of Knight Therapeutics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 233.89%
Maximum Annual PE Ratio = 124.77
Minimum Annual Increase = -484.64%
Minimum Annual PE Ratio = -112.04
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -112.04 | -189.80% |
| 2024 | 124.77 | -484.64% |
| 2023 | -32.44 | 62.81% |
| 2022 | -19.92 | -148.87% |
| 2021 | 40.77 | 82.89% |
| 2020 | 22.29 | -70.59% |
| 2019 | 75.80 | 67.57% |
| 2018 | 45.24 | -33.48% |
| 2017 | 68.00 | -5.03% |
| 2016 | 71.60 | 233.89% |
Knight Therapeutics Inc. (KHTRF) Average PE Ratio
How has KHTRF PE Ratio performed in the past?
The current PE Ratio of Knight Therapeutics Inc. (KHTRF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-6.57
5-year avg
0.23
10-year avg
28.41
Knight Therapeutics Inc. (KHTRF) PE Ratio vs. Peers
How is KHTRF’s PE Ratio compared to its peers?
Knight Therapeutics Inc.’s PE Ratio is greater than Hua Medicine (Shanghai) Ltd. (1.67), greater than Cresco Labs Inc. (-2.03), greater than Verano Holdings Corp. (-1.55), greater than PureTech Health plc (-3.77), greater than Surgical Science Sweden AB (publ) (29.90), greater than Allergy Therapeutics plc (-7.07), greater than Avacta Group Plc (-7.84), greater than COLTENE Holding AG (20.32), greater than Vitalhub Corp. (58.60), greater than BioInvent International AB (publ) (-4.54),
| Company | PE Ratio | Market cap |
|---|---|---|
| 1.67 | $338.92M | |
| -2.03 | $286.92M | |
| -1.55 | $470.36M | |
| -3.77 | $413.81M | |
| 29.90 | $204.10M | |
| -7.07 | $655.46M | |
| -7.84 | $468.40M | |
| 20.32 | $365.45M | |
| 58.60 | $318.83M | |
| -4.54 | $216.40M |
Build a custom stock screener for Knight Therapeutics Inc. (KHTRF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Knight Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Knight Therapeutics Inc. (KHTRF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Knight Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is Knight Therapeutics Inc.'s PE Ratio?
How is the PE Ratio calculated for Knight Therapeutics Inc. (KHTRF)?
What is the highest PE Ratio for Knight Therapeutics Inc. (KHTRF)?
What is the 3-year average PE Ratio for Knight Therapeutics Inc. (KHTRF)?
What is the 5-year average PE Ratio for Knight Therapeutics Inc. (KHTRF)?
How does the current PE Ratio for Knight Therapeutics Inc. (KHTRF) compare to its historical average?